Select Medical Goes Private in $3.9B Welsh Carson-Led Deal

Bypaulgruensfelder
The Philadelphia Inquirer July 3, 2026
Read Full Article →
AI-Generated Summary

Select Medical Holdings completed a $3.9 billion take-private on July 1, 2026, led by its founders and private equity firm Welsh, Carson, Anderson & Stowe at $16.50 per share — an 18% premium to its pre-announcement close. The Mechanicsburg, Pa.–based operator runs outpatient physical therapy (including NovaCare) across roughly 1,850 locations in 36 states, plus 104 long-term acute-care hospitals and 38 rehabilitation hospitals, with more than 45,000 employees and $5.5 billion in 2025 revenue. Management rolled equity alongside the sponsor — a structure that keeps operating leadership invested through the next value-creation cycle in post-acute and outpatient rehab.

Why It Matters

Founder-and-management rollover alongside a PE sponsor signals confidence in post-acute and outpatient rehab economics even amid reimbursement pressure. For multi-site operators, the deal is a reference point on take-private structuring, scale premiums, and how sponsors underwrite platforms spanning outpatient and facility-based care.

healthcare M&A take-private Welsh Carson post-acute care outpatient rehab management rollover

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

How big was the Select Medical take-private, and who led it?

Select Medical was taken private in a $3.9 billion deal that closed July 1, 2026, led by Executive Chairman Robert Ortenzio, Senior EVP Martin Jackson, and private equity firm Welsh, Carson, Anderson & Stowe. Shareholders received $16.50 per share, an 18% premium to the close before the November 2025 announcement.

What does Select Medical operate after going private?

Select Medical runs outpatient physical therapy — including NovaCare — across about 1,850 locations in 36 states, plus 104 long-term acute-care hospitals in 28 states and 38 rehabilitation hospitals in 15 states. It employs more than 45,000 people and reported $5.5 billion in revenue last year.

Why does management rolling equity into a PE deal matter to operators?

When founders and senior management reinvest alongside a private equity sponsor, it aligns leadership with the sponsor’s value-creation plan and signals conviction in the platform’s forward economics. For multi-site healthcare operators, it is a template for take-private structuring that retains operating continuity through the hold period.

Similar Posts

  • Healthcare M&A Trends Q2 2026: PPM, Outpatient, and PE Scrutiny

    Bypaulgruensfelder

    Healthcare M&A stayed steady in Q2 2026, driven by consolidation, AI integration, and cross-sector deals despite intensifying scrutiny of PE-backed MSO arrangements. Physician practice management remained active, with enablement platforms like Privia Health offering an alternative to full-ownership roll-ups. Ascension closed its AMSURG acquisition to become the third-largest ambulatory surgery center platform. For-profit systems kept divesting non-core assets—CHS sold Crestwood Medical Center for $459 million and four Arkansas hospitals to Freeman Health, part of a $1.2 billion, nine-hospital divestiture plan. Home health, hospice, and behavioral health saw continued PE-backed roll-ups, while digital health and health IT capital concentrated around scaled, high-performing platforms amid tariff-driven volatility and antitrust pressure.

  • Commure Targets the 35–50% of Referrals That Never Convert

    Bypaulgruensfelder

    Between 35% and 50% of medical referrals never result in a completed specialist appointment, and those that do take 31 days on average — a gap Commure’s new Orchestrator platform aims to close by automating end-to-end referral management and patient intake. The AI platform replaces fax-based referral workflows, targets referral leakage, and cuts pre-visit administrative work such as authorization holds and manual hand-offs. Commure frames the economics plainly: every unconverted referral is both a patient lost to follow-up and revenue that never shows up on the books. The launch adds to a fast-growing category of AI tools aimed at the pre-visit workflow, where leakage and intake friction remain among the most measurable revenue drains for multi-site provider groups.

  • Allina Health to Pay $12.5M to Settle Website Pixel Litigation

    Bypaulgruensfelder

    Allina Health System agreed to pay $12.5 million to resolve a consolidated class action over its use of website tracking pixels, one of the larger settlements in the ongoing healthcare pixel litigation wave. Plaintiffs alleged the tools disclosed personally identifiable information and protected health information to third parties including Meta and Google, in violation of the Electronic Communications Privacy Act, the Minnesota Health Records Act, and state deceptive trade practices law. Allina denies wrongdoing. The fund splits into $10.3 million for patient portal, bill-pay, and scheduling users and $2.2 million for other patients, covering activity from September 2018 through May 2026.

  • Federal Court Strikes Down South Dakota Dental Advertising Restrictions

    Bypaulgruensfelder

    A federal court struck down South Dakota’s dental advertising restrictions, ruling that dentists may market bona fide credentials—including implant dentistry—even in areas the American Dental Association does not formally recognize as specialties. On July 20, 2026, U.S. District Judge Karen Schreier granted summary judgment to the American Academy of Implant Dentistry and Sioux Falls dentist Dr. Edward Kusek, and denied the South Dakota Board of Dentistry and Attorney General Marty Jackley. The plaintiffs argued the Board’s 2023 rules violated First Amendment commercial-speech protections. The decision tracks earlier AAID victories against the Texas, California, and Florida boards, reinforcing that truthful, non-misleading specialty advertising by dentists is constitutionally protected.

  • HCA Explores Rebranding TriStar Hospitals Under Its Own Name

    Bypaulgruensfelder

    HCA Healthcare is exploring a rebrand of its TriStar Division, potentially bringing its Nashville-area hospitals under the national HCA name, according to bid proposal documents for Williamson Health obtained by the Nashville Business Journal through a public records request. The move would fold a long-standing regional brand into HCA’s corporate identity, signaling that the country’s largest for-profit hospital operator may favor a unified master brand over locally recognized division names. While the plans remain preliminary and tied to HCA’s pursuit of Williamson Health, the documents show brand architecture is an active consideration in how HCA positions its facilities across competitive local markets.

  • Dentalcorp Enters U.S. Market With Northstar Dental Acquisition

    Bypaulgruensfelder

    Dentalcorp, one of North America’s largest dental support organizations, has entered the U.S. market by acquiring Northstar Dental Partners, a Boca Raton-based group supporting 21 practices across Florida. The deal, with terms undisclosed, expands Dentalcorp’s network to more than 650 supported practices and roughly six million annual patient visits, and marks the Canadian DSO’s first move south of the border. Founder Dr. Jordan Tomalty retains an ownership stake and a leadership role. For Dentalcorp, Florida provides a foothold in one of the fastest-growing U.S. healthcare markets and a platform for further acquisitions in a still-fragmented dental landscape.